Evidence map›Paper›PMID 36178937›Full record

ArticleJCO oncology practice2023

Fostering a High-Functioning Team in Cancer Care Using the 4R Oncology Model: Assessment in a Large Health System and a Blueprint for Other Institutions.

Raymond Liu, Christine B Weldon, Elizabeth Linehan, Nancy Gordon, Thea Abbe, Marti Hennings, Henie James, Jed Katzel, Chun Ng, Megumi Tomita and 9 more

Abstract read
In one paragraph

Article in JCO oncology practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Use of Cancer Survivorship Care Guidelines by Primary Care Providers in the United States.Journal of the American Board of Family Medicine : JABFM · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Raymond LiuDepartment of Hematology Oncology, The Permanente Medical Group, San Francisco, CA.ORCID 0000-0002-4667-9632
Christine B WeldonCenter for Business Models in Healthcare, Glencoe, IL.ORCID 0000-0003-3918-0048
Elizabeth LinehanDepartment of Hematology Oncology, The Permanente Medical Group, San Francisco, CA.
Nancy GordonDivision of Research, Kaiser Permanente Northern California, Oakland, CA.ORCID 0000-0003-3692-112X
Thea AbbeDepartment of Hematology Oncology, The Permanente Medical Group, San Francisco, CA.
Marti HenningsDepartment of Hematology Oncology, The Permanente Medical Group, Modesto, CA.
Henie JamesDepartment of Hematology Oncology, The Permanente Medical Group, Oakland, CA.
Jed KatzelDepartment of Hematology Oncology, The Permanente Medical Group, San Francisco, CA.ORCID 0000-0002-3037-018X
Chun NgDepartment of Hematology Oncology, The Permanente Medical Group, Modesto, CA.
Megumi TomitaDepartment of Hematology Oncology, The Permanente Medical Group, Modesto, CA.
Jeffrey B VelottaDepartment of Hematology Oncology, The Permanente Medical Group, Oakland, CA.
Stephanie OssowskiDepartment of Hematology Oncology, The Permanente Medical Group, San Francisco, CA.ORCID 0000-0003-2260-4545
Lori C SakodaDivision of Research, Kaiser Permanente Northern California, Oakland, CA.ORCID 0000-0002-0900-5735
Sharon Likely SpragueDepartment of Hematology Oncology, The Permanente Medical Group, Modesto, CA.ORCID 0000-0003-3792-017X
Anna DowlingDepartment of Hematology Oncology, The Permanente Medical Group, San Francisco, CA.
Kimberly BeringerDepartment of Hematology Oncology, The Permanente Medical Group, San Francisco, CA.
Arliene RaveloGenentech, Inc, South San Francisco, CA.ORCID 0000-0001-7554-3008
Elaine YuGenentech, Inc, South San Francisco, CA.
Julia R TrosmanCenter for Business Models in Healthcare, Glencoe, IL.ORCID 0000-0002-5583-2301

Funding

ECOG-ACRIN NCORP Research Base - TMISTUG1CA189828 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · 2014 to 2026
$199.7M
NCI NIH HHS UG1 CA189828
6 · The paper itself

Abstract

purposeDelivering cancer care by high-functioning multidisciplinary teams promises to address care fragmentation, which threatens care quality, affects patient outcomes, and strains the oncology workforce. We assessed whether the 4R Oncology model for team-based interdependent care delivery and patient self-management affected team functioning in a large community-based health system.

methods4R was deployed at four locations in breast and lung cancers and assessed along four characteristics of high-functioning teams: recognition as a team internally and externally; commitment to an explicit shared goal; enablement of interdependent work to achieve the goal; and engagement in regular reflection to adapt objectives and processes.

resultsWe formed an internally and externally recognized team of 24 specialties committed to a shared goal of delivering multidisciplinary care at the optimal time and sequence from a patient-centric viewpoint. The team conducted 40 optimizations of interdependent care (22 for breast, seven for lung, and 11 for both cancers) at four points in the care continuum and established an ongoing teamwork adaptation process. Half of the optimizations entailed low effort, while 30% required high level of effort; 78% resulted in improved process efficiency.

conclusion4R facilitated development of a large high-functioning team and enabled 40 optimizations of interdependent care along the cancer care continuum in a feasible way. 4R may be an effective approach for fostering high-functioning teams, which could contribute to improving viability of the oncology workforce. Our intervention and taxonomy of results serve as a blueprint for other institutions motivated to strengthen teamwork to improve patient-centered care.

Indexed as

Medical OncologyNeoplasmsBreastContinuity of Patient CareDelivery of Health CareHumansPatient-Centered Care

Identifiers

PMID36178937
PMCPMC10166419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.